Takagi Hideaki, Numazaki Maki, Kajiwara Toshimitsu, Abe Yu, Ishii Mariko, Kato Chiaki, Kojima Naoya
Institute of Glycoscience, Department of Applied Biochemistry, Tokai University, Hiratsuka, Kanagawa 259-1292, Japan.
Glycobiology. 2009 Mar;19(3):258-66. doi: 10.1093/glycob/cwn128. Epub 2008 Nov 24.
Resident peritoneal macrophages (PEMs) express SIGNR1 on the cell surface as a major mannose receptor. These cells also ingest oligomannose-coated liposomes (OMLs) in an oligomannose-dependent manner following intraperitoneal administration. Therefore, the current study was conducted to investigate the possible role of SIGNR1 in capture of OMLs. Transient expression of several SIGN-related lectins potentially expressed on PEMs in CHO cells revealed that only SIGNR1 contributed to capture of OMLs. When SIGNR1 was introduced into mouse macrophage-like RAW264.7 cells, SIGNR1-expressing RAW (RAW-SIGNR1) cells recognized OMLs under serum-free conditions. OML recognition by RAW-SIGNR1 cells as well as that by PEMs was partially inhibited by an anti-SIGNR1 antibody (ER-TR9) and by mannan, and completely inhibited by EDTA. Interestingly, OML recognition by RAW-SIGNR1 cells was accelerated in the presence of serum, partially inhibited by an anti-complement receptor 3 (CR3) antibody (M1/70), and almost completely inhibited by a combination of ER-TR9 and M1/70. Complete inhibition of OML ingestion by the combination of ER-TR9 and M1/70 was also observed under serum-free conditions, suggesting that SIGNR1 and CR3 cooperate in an additive way in capture of OMLs by macrophage-like RAW cells. Administration of ER-TR9 or M1/70 into the peritoneal cavity led to a significant decrease of OML uptake by PEMs. Therefore, SIGNR1 expressed on macrophages acts as a receptor for recognition of OMLs under physiological conditions.
驻留腹膜巨噬细胞(PEMs)在细胞表面表达SIGNR1作为主要的甘露糖受体。这些细胞在腹腔注射后也以甘露糖依赖的方式摄取寡甘露糖包被的脂质体(OMLs)。因此,本研究旨在探讨SIGNR1在捕获OMLs中的可能作用。在CHO细胞中瞬时表达几种可能在PEMs上表达的SIGN相关凝集素,结果显示只有SIGNR1有助于捕获OMLs。当将SIGNR1导入小鼠巨噬细胞样RAW264.7细胞时,表达SIGNR1的RAW(RAW-SIGNR1)细胞在无血清条件下能够识别OMLs。RAW-SIGNR1细胞以及PEMs对OMLs的识别被抗SIGNR1抗体(ER-TR9)和甘露聚糖部分抑制,被EDTA完全抑制。有趣的是,在有血清存在的情况下,RAW-SIGNR1细胞对OMLs的识别加速,被抗补体受体3(CR3)抗体(M1/70)部分抑制,被ER-TR9和M1/70的组合几乎完全抑制。在无血清条件下也观察到ER-TR9和M1/70的组合完全抑制了OMLs的摄取,这表明SIGNR1和CR3在巨噬细胞样RAW细胞捕获OMLs过程中以累加方式协同作用。向腹腔内注射ER-TR9或M1/70会导致PEMs对OMLs的摄取显著减少。因此,巨噬细胞表面表达的SIGNR1在生理条件下作为识别OMLs的受体发挥作用。